These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 16095153)

  • 41. Microparticles (MPs), tissue factor (TF) and tissue factor inhibitor (TFPI) in cord blood plasma. A preliminary study and literature survey of procoagulant properties of MPs.
    Uszyński M; Zekanowska E; Uszyński W; Kuczyński J; Zyliński A
    Eur J Obstet Gynecol Reprod Biol; 2011 Sep; 158(1):37-41. PubMed ID: 21664032
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The impact of tissue factor pathway inhibitor on coagulation kinetics determined by thrombelastography.
    Audu P; Nielsen VG; Armstead V; Powell G; Kim J; Kim L; Mehta M
    Anesth Analg; 2006 Oct; 103(4):841-5. PubMed ID: 17000790
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum surfactant protein D is elevated in allergic patients.
    Koopmans JG; van der Zee JS; Krop EJ; Lopuhaä CE; Jansen HM; Batenburg JJ
    Clin Exp Allergy; 2004 Dec; 34(12):1827-33. PubMed ID: 15663555
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 4-1 BB stimulation inhibits allergen-specific immunoglobulin E production and airway hyper-reactivity but partially suppresses bronchial eosinophilic inflammation in a mouse asthma model.
    Cho YS; Kwon B; Lee TH; Kim TB; Moon KA; La S; Lee J; Lee SD; Oh YM; Moon HB
    Clin Exp Allergy; 2006 Mar; 36(3):377-85. PubMed ID: 16499650
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early and late phase asthmatic response in lower airways of cat-allergic asthmatic patients--a comparison between experimental and environmental allergen challenge.
    Arvidsson MB; Löwhagen O; Rak S
    Allergy; 2007 May; 62(5):488-94. PubMed ID: 17441789
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasminogen activator inhibitor-1 plasma concentration in allergic asthma patients during allergen challenge.
    Kowal K; Bodzenta-Lukaszyk A; Pampuch A; Szmitkowski M; Donati MB; Iacoviello L
    Int Arch Allergy Immunol; 2007; 144(3):240-6. PubMed ID: 17579282
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of a single inhaled dose of a VLA-4 antagonist on allergen-induced airway responses and airway inflammation in patients with asthma.
    Ravensberg AJ; Luijk B; Westers P; Hiemstra PS; Sterk PJ; Lammers JW; Rabe KF
    Allergy; 2006 Sep; 61(9):1097-103. PubMed ID: 16918513
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor.
    Hackeng TM; Seré KM; Tans G; Rosing J
    Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3106-11. PubMed ID: 16488980
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of disodium cromoglycate and beclomethasone dipropionate on the asthmatic response to allergen challenge II. Late response (LAR).
    Pelikan Z; Pelikan-Filipek M; Remeijer L
    Ann Allergy; 1988 Mar; 60(3):217-25. PubMed ID: 3126682
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dynamics of the lymphocyte beta-adrenoceptor system in patients with allergic bronchial asthma.
    Meurs H; Koëter GH; de Vries K; Kauffman HF
    Eur J Respir Dis Suppl; 1984; 135():47-61. PubMed ID: 6329809
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tissue factor/its pathway inhibitor system and kynurenines in chronic kidney disease patients on conservative treatment.
    Pawlak K; Tankiewicz J; Mysliwiec M; Pawlak D
    Blood Coagul Fibrinolysis; 2009 Oct; 20(7):590-4. PubMed ID: 19491664
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Elevated tissue factor circulating levels in children with hemolytic uremic syndrome caused by verotoxin-producing E. coli.
    Kamitsuji H; Nonami K; Murakami T; Ishikawa N; Nakayama A; Umeki Y
    Clin Nephrol; 2000 May; 53(5):319-24. PubMed ID: 11305804
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of plasma tissue factor and tissue factor pathway inhibitor levels in childhood hemangiomas.
    Türker M; Irken G; Oren H; Yilmaz S; Yüksel F; Olgun N
    Pediatr Blood Cancer; 2006 Dec; 47(7):914-7. PubMed ID: 16395682
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inflammation and the late phase reaction in asthma: the effect of polymorphonuclear leukocyte depletion on airways obstruction and bronchial hyperreactivity in an animal model.
    Murphy KR; Marsh WR; Glezen LS; Irvin CG; Wilson MC; Larsen GL
    Bull Eur Physiopathol Respir; 1986; 22 Suppl 7():48-53. PubMed ID: 3955267
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inflammation and functional outcome in diisocyanate-induced asthma after cessation of exposure.
    Piirilä PL; Meuronen A; Majuri ML; Luukkonen R; Mäntylä T; Wolff HJ; Nordman H; Alenius H; Laitinen A
    Allergy; 2008 May; 63(5):583-91. PubMed ID: 18394133
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The changes in plasma beta-thromboglobulin (beta-TG), platelet factor 4 (PF4) and thromboxane B2 (TXB2) after a bronchial provocation test (BPT) with house dust (HD) allergen].
    Mizuno M; Adachi M; Maruyama S; Suganuma T; Okada T; Takahashi T
    Arerugi; 1991 May; 40(5):500-5. PubMed ID: 1831967
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Allergic rhinitis with hyper-responsiveness differ from asthma in degree of peripheral obstruction during metacholine challenge test.
    Aronsson D; Tufvesson E; Ankerst J; Bjermer L
    Clin Physiol Funct Imaging; 2008 Mar; 28(2):81-5. PubMed ID: 18034849
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Roflumilast, a phosphodiesterase 4 inhibitor, reduces airway hyperresponsiveness after allergen challenge.
    Louw C; Williams Z; Venter L; Leichtl S; Schmid-Wirlitsch C; Bredenbroker D; Bardin PG
    Respiration; 2007; 74(4):411-7. PubMed ID: 16954654
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Changes of TF and TFPI activities in patients with hypertension or coronary atherosclerotic heart disease].
    Xiao Z; Wang W; Han J; He X; Li J
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(3):251-2, 255. PubMed ID: 12016797
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Optimisation of the sensitisation conditions for an ovalbumin challenge model of asthma.
    Smith N; Broadley KJ
    Int Immunopharmacol; 2007 Feb; 7(2):183-90. PubMed ID: 17178385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.